Health Care & Life Sciences » Biotechnology | BioRestorative Therapies Inc.

BioRestorative Therapies Inc.

BioRestorative Therapies Inc.
Stock Exchange Other OTC
EPS
$1.53
Market Cap
$4.73 M
Shares Outstanding
17.48 M
Public Float
8.49 M

Profile

Address
40 Marcus Drive
Melville New York 11747
United States
Employees -
Website http://www.biorestorative.com
Updated 07/08/2019
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures.

Financials

View All
Created with Highcharts 5.0.14BioRestorative Therapies Inc.Net Income. Fiscal year is January-December. All values USD Thousands.5 7515 7515 5875 5877 9237 9238 6368 6369 4449 44412 51712 51720132014201520162017201802.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14BioRestorative Therapies Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.11416416628628363681811111112013201420152016201720180200400600800

Mark Weinreb
Chairman, President, CEO, CFO & CAO
Robert B. Catell
Independent Director